Rankings
Best Tirzepatide Providers
Tirzepatide is the dual GIP/GLP-1 agonist in Mounjaro and Zepbound, and it produced the largest average weight loss of any medication in this class in trials. It also costs more than semaglutide almost everywhere. These are the providers whose tirzepatide pricing we verified.
How this page is built:rankings draw on our individual provider reviews, and every price shown was checked against the provider's own site on 7 August 2026. Providers appear here only where we could verify the specific figures the ranking depends on — an absence means we lacked verified data, not that a provider was judged poorly. Prices change frequently; confirm your own quote before paying.
Fewer entries than the semaglutide page, deliberately.Many providers advertise tirzepatide without publishing a price, or quote a "from" figure tied to a microdose. We only list providers whose tirzepatide pricing we could actually verify.
Affiliate disclosure: GLP1Drugs.org earns a commission if you sign up with some providers listed here. It does not change the order of these rankings or the caveats attached to each entry. See our affiliate disclosure.
Ranked By Verified Price
| # | Provider | Rating | Tirzepatide | States | Stands out for | Know before you buy |
|---|---|---|---|---|---|---|
| 1 | Telos Rx | ★ 4.1 | $49/month intro | — | LegitScript-certified newcomer with quarterly labs and 48-hour shipping | $49 is microdosed intro pricing — confirm the ongoing rate and dose |
| 2 | Trimi Health | ★ 4.6 | $125/month | — | Flat pricing at every dose on both molecules, with free overnight shipping | Compounded only — no brand-name or insurance route |
| 3 | Cora Health | ★ 4.2 | $135/month | All 50 states | Two named PCAB-accredited pharmacies, all-inclusive pricing on both molecules, HSA/FSA accepted | The headline rates need an annual commitment — monthly terms run to $175 and $225 |
| 4 | Bodybuilding Health+ | ★ 3.4 | $139/month | — | Honest compounding disclosure and a clear price ladder down to $139 on an annual plan | The consult fee is non-refundable even if a clinician declines you |
| 5 | Gala Health | ★ 4.2 | $149/month | — | The cheapest verified compounded tirzepatide, with flat dose pricing | Tirzepatide-focused; does not name its pharmacy partners |
| 6 | Piper | ★ 4.6 | $199/month | — | Overnight shipping with flat-rate pricing on both molecules | Tirzepatide costs meaningfully more than the cheapest platforms |
| 7 | Shed (formerly ShedRx) | ★ 4.3 | ~$239/month | — | The widest format range anywhere: injections, drops, lozenges, FDA-approved oral Foundayo, plus Wegovy and Zepbound | 250 BBB complaints in three years, clustered on billing after cancellation |
| 8 | Amazon One Medical | ★ 4.7 | $299/month (brand Zepbound) | All 50 states | FDA-approved medication at a published cash price — $299/month for injectables, $149/month for oral Foundayo, from $25/month insured — with no membership required | Costs more than compounded cash-pay; you are paying for an approved product |
Note how much wider the spread is than on semaglutide. A $49 microdosed introductory rate and a $239 full-dose monthly price are not the same product, and comparing them on headline price alone will mislead you. Ask any provider quoting under about $130 what dose that price covers and what it becomes once you titrate.
Why Tirzepatide Costs More
The trial evidence
In SURMOUNT-1, adults with obesity or overweight without diabetes taking tirzepatide 15 mg lost a mean of 20.9% of body weight at 72 weeks, against 3.1% on placebo. That is the largest average reduction reported for any medication in this class, and it is the main reason tirzepatide commands a premium. Its body composition profile also looked better than semaglutide's: the SURMOUNT-1 substudy put the lean-tissue share of weight lost at roughly 25%, against about 45% in the STEP 1 substudy.
Those figures describe the branded product
SURMOUNT-1 studied Zepbound's active ingredient at approved doses under trial conditions. Compounded tirzepatide is not FDA-approved, has not been through equivalent trials, and is not equivalent to Mounjaro or Zepbound beyond the shared active ingredient. Tirzepatide came off the FDA shortage list in December 2024, which further narrows the lawful basis for routinely compounding copies of it.
Beware the microdose quote
Several providers advertise tirzepatide from $49 to $99. In most cases that figure buys a microdosed protocol well below the doses studied in SURMOUNT-1. Microdosing is a legitimate approach for tolerability, and some people do well on it — but it is not the treatment the 20.9% figure came from, and it should not be priced as though it were. Get the milligram dose in writing alongside the price.
Keep reading
Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting or changing any treatment. Compounded medications are not FDA-approved, are not evaluated by the FDA for safety, effectiveness or quality, and are not equivalent to the branded drug beyond sharing an active ingredient. GLP-1 medications commonly cause nausea, vomiting, diarrhoea and constipation, and carry risks including pancreatitis, gallbladder disease and kidney injury; they are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, and should not be used in pregnancy, when trying to conceive, or while breastfeeding. Prescribing is subject to clinician approval and is never guaranteed. Individual results vary and no outcome is promised.